PELLINI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 477
EU - Europa 431
AS - Asia 160
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
SA - Sud America 2
Totale 1.076
Nazione #
US - Stati Uniti d'America 477
GB - Regno Unito 156
CN - Cina 146
SE - Svezia 61
IT - Italia 57
IE - Irlanda 44
FR - Francia 40
DE - Germania 31
FI - Finlandia 25
KR - Corea 8
UA - Ucraina 6
BE - Belgio 4
RU - Federazione Russa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CL - Cile 2
EU - Europa 2
NL - Olanda 2
NO - Norvegia 2
TW - Taiwan 2
BD - Bangladesh 1
IN - India 1
IR - Iran 1
PH - Filippine 1
Totale 1.076
Città #
Southend 146
Chandler 127
Woodbridge 58
Dublin 44
Beijing 34
Jacksonville 34
Ann Arbor 31
Ashburn 31
Bologna 19
New York 16
Wilmington 16
Jinan 15
Nanjing 15
Lawrence 14
Princeton 14
Hebei 11
Houston 11
Shenyang 11
Verona 11
Helsinki 8
Seoul 8
Tianjin 7
Haikou 6
Seattle 6
Düsseldorf 5
Brugnera 4
Brussels 4
Changsha 4
Guangzhou 4
Ningbo 4
Redwood City 4
Sindelfingen 4
Zhengzhou 4
Fort Wayne 3
Hangzhou 3
Los Angeles 3
Nanchang 3
Augusta 2
Boardman 2
Dearborn 2
Fremont 2
Hanover 2
Jiaxing 2
Lancaster 2
San Mateo 2
Udine 2
Almere Stad 1
Ardabil 1
Bangalore 1
Changle 1
Chengdu 1
Clearwater 1
Dhaka 1
Fairfield 1
Groningen 1
Lanzhou 1
Lincoln 1
London 1
Ludwigshafen am Rhein 1
Manila 1
Milan 1
Modesto 1
Norwalk 1
Novokuznetsk 1
Padova 1
Pozza 1
Redmond 1
San Diego 1
San Francisco 1
Sydney 1
Taizhou 1
Totale 785
Nome #
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 115
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 99
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 96
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 94
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 87
Role of dual-point FDG PET/CT in prone position and fused PET/MR; correlation with biologic prognostic parameters in breast cancer 84
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 77
Breast cancer and gastrointestinal metastasis. A case report and review of the literature 75
Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy 71
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research 68
Cystic tumors of the breast: a diagnostic and therapeutical problem. 67
Comparison between invasive breast cancer with extensive peritumoral vascular invasion and inflammatory breast carcinoma: a clinicopathologic study of 161 cases 66
Multidisciplinary management of CDH1 germinal mutation and prophylactic management hereditary lobular breast cancer: A case report 58
A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in a multi-center series of resected early stage pure invasive lobular breast carcinoma (ILC) 42
Totale 1.099
Categoria #
all - tutte 3.192
article - articoli 2.749
book - libri 0
conference - conferenze 443
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 7 7
2019/2020129 13 5 0 4 8 19 17 6 26 5 11 15
2020/2021133 12 44 2 20 19 9 2 2 5 3 14 1
2021/2022130 5 49 0 15 7 1 0 6 6 2 7 32
2022/2023314 19 52 24 60 21 76 2 20 30 1 6 3
2023/2024128 7 3 6 23 29 26 7 15 3 9 0 0
Totale 1.099